Journal ArticleOPEN ACCESS

Profile of lanreotide autogel and its potential in the treatment of gastroenteropancreatic neuroendocrine tumors

  • Rinke A
  • Mueller D
Gastrointestinal Cancer: Targets and Therapy (2015) 123
DOI: 10.2147/gictt.s70701
N/ACitations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

… with the availability of the mTOR inhibitor everolimus and the multikinase inhibitor sunitinib. Both … Everolimus in combination with octreotide long-acting repeatable (LAR) has also been …

Cite

CITATION STYLE

APA

Rinke, A., & Mueller, D. (2015). Profile of lanreotide autogel and its potential in the treatment of gastroenteropancreatic neuroendocrine tumors. Gastrointestinal Cancer: Targets and Therapy, 123. https://doi.org/10.2147/gictt.s70701

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free